DK3302704T3 - Sammensætninger og fremgangsmåder til anvendelse af beta-hydroxy-beta-methylbutyrat (hmb) til reduktion af fedtmasse - Google Patents

Sammensætninger og fremgangsmåder til anvendelse af beta-hydroxy-beta-methylbutyrat (hmb) til reduktion af fedtmasse Download PDF

Info

Publication number
DK3302704T3
DK3302704T3 DK16804333.9T DK16804333T DK3302704T3 DK 3302704 T3 DK3302704 T3 DK 3302704T3 DK 16804333 T DK16804333 T DK 16804333T DK 3302704 T3 DK3302704 T3 DK 3302704T3
Authority
DK
Denmark
Prior art keywords
beta
hmb
hydroxy
compositions
methods
Prior art date
Application number
DK16804333.9T
Other languages
English (en)
Inventor
John Rathmacher
Naji Abumrad
Shawn Baier
Original Assignee
Metabolic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolic Tech Inc filed Critical Metabolic Tech Inc
Application granted granted Critical
Publication of DK3302704T3 publication Critical patent/DK3302704T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
DK16804333.9T 2015-06-01 2016-06-01 Sammensætninger og fremgangsmåder til anvendelse af beta-hydroxy-beta-methylbutyrat (hmb) til reduktion af fedtmasse DK3302704T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562169334P 2015-06-01 2015-06-01
PCT/US2016/035273 WO2016196637A1 (en) 2015-06-01 2016-06-01 Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (hmb) for decreasing fat mass

Publications (1)

Publication Number Publication Date
DK3302704T3 true DK3302704T3 (da) 2023-02-13

Family

ID=57397749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16804333.9T DK3302704T3 (da) 2015-06-01 2016-06-01 Sammensætninger og fremgangsmåder til anvendelse af beta-hydroxy-beta-methylbutyrat (hmb) til reduktion af fedtmasse

Country Status (15)

Country Link
US (3) US20160346238A1 (da)
EP (1) EP3302704B1 (da)
JP (1) JP6858714B2 (da)
CN (2) CN117257783A (da)
AU (2) AU2016271395A1 (da)
CA (1) CA2987934A1 (da)
DK (1) DK3302704T3 (da)
ES (1) ES2937282T3 (da)
FI (1) FI3302704T3 (da)
HK (1) HK1252405A1 (da)
HU (1) HUE061747T2 (da)
MX (1) MX2017015418A (da)
PL (1) PL3302704T3 (da)
PT (1) PT3302704T (da)
WO (1) WO2016196637A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11406609B2 (en) 2016-01-21 2022-08-09 Metabolic Technologies, Inc. Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for modulating autophagy and lipophagy
MX2018008903A (es) * 2016-01-21 2019-02-21 Metabolic Tech Inc COMPOSICIONES Y METODOS DE USO DE ß-HIDROXI-ß-METILBUTIRATO (HMB) PARA MODULAR AUTOFAGIA Y LIPOFAGIA.
EP3474834A1 (en) 2016-06-27 2019-05-01 The General Hospital Corporation Dba Massachusetts General Hospital Stimulating platelet generation by activating mitochondrial biogenesis
KR20200131810A (ko) * 2018-01-05 2020-11-24 텍사스 테크 유니버시티 오피스 오브 리서치 커머셜라이제이션 간헐적 금식과 관련된 β-하이드록시-β-메틸부티레이트 (HMB)의 조성물 및 사용 방법
JP7202800B2 (ja) * 2018-07-13 2023-01-12 ライオン株式会社 水分散性組成物、食品組成物、水分散液及び泡立ち抑制方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028440A (en) 1990-01-30 1991-07-02 Iowa State University Research Foundation, Inc. Method of raising meat producing animals to increase lean tissue development
US6031000A (en) * 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
US20050215640A1 (en) * 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
US20080161929A1 (en) 2006-12-29 2008-07-03 Mccormack Bruce Cervical distraction device
WO2009066303A2 (en) * 2007-11-22 2009-05-28 Ganga Raju Gokaraju New synergistic phytochemical composition for the treatment of obesity
ES2689700T3 (es) * 2008-12-09 2018-11-15 Metabolic Technologies, Inc. Intervención nutricional para mejorar la función y resistencia muscular
ES2608483T3 (es) * 2009-12-18 2017-04-11 Metabolic Technologies, Inc. Método mejorado de administración de beta-hidroxi-beta-metilbutirato (HMB)
CN108261547A (zh) * 2011-07-15 2018-07-10 纽斯尔特科学公司 用于调节代谢途径的组合物和方法
US9943517B2 (en) * 2012-11-13 2018-04-17 Nusirt Sciences, Inc. Compositions and methods for increasing energy metabolism
JP2016538247A (ja) * 2013-10-09 2016-12-08 ネステク ソシエテ アノニム シトルリン及びロイシンを含む組成物、並びに糖尿病及びメタボリック症候群の治療におけるその使用
WO2015105981A2 (en) * 2014-01-09 2015-07-16 Abbott Laboratories Conditional essentiality of hmb

Also Published As

Publication number Publication date
ES2937282T3 (es) 2023-03-27
US10772856B2 (en) 2020-09-15
BR112017025788A2 (pt) 2018-08-07
JP6858714B2 (ja) 2021-04-14
PL3302704T3 (pl) 2023-05-22
US20160346238A1 (en) 2016-12-01
PT3302704T (pt) 2023-02-13
US20180098951A1 (en) 2018-04-12
AU2019203595A1 (en) 2019-06-13
JP2018516934A (ja) 2018-06-28
EP3302704A4 (en) 2019-03-06
MX2017015418A (es) 2018-08-24
CA2987934A1 (en) 2016-12-08
EP3302704A1 (en) 2018-04-11
AU2016271395A1 (en) 2017-12-21
CN117257783A (zh) 2023-12-22
HUE061747T2 (hu) 2023-08-28
HK1252405A1 (zh) 2019-05-24
US20200405668A1 (en) 2020-12-31
WO2016196637A1 (en) 2016-12-08
EP3302704B1 (en) 2023-01-25
AU2019203595B2 (en) 2020-11-19
FI3302704T3 (fi) 2023-02-28
CN107847759A (zh) 2018-03-27

Similar Documents

Publication Publication Date Title
DK3356529T3 (da) Sammensætninger og fremgangsmåder til hæmning af genekspression af lpa
DK3386484T3 (da) Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler
DK3484469T3 (da) Sammensætninger og fremgangsmåder til potentiering af antimikrober
DK3782639T3 (da) Sammensætninger og fremgangsmåder til internalisering af enzymer
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
DK3390430T3 (da) Human immundefektvirus-antigener, vektorer, sammensætninger og fremgangsmåder til anvendelse deraf
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3240895T3 (da) Sammensætninger og fremgangsmåder til proteinglykosylering
DK3393655T3 (da) Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme
DK3394065T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf
DK3394259T3 (da) Sammensætninger og fremgangsmåder til reducering af tau-ekspression
DK3261644T3 (da) Sammensætninger og fremgangsmåder til behandling af nethindenedbrydning
DK3102184T3 (da) Stabile formuleringer af peptider og fremgangsmåder til fremstilling
DK3606929T3 (da) Beta-nicotinat-ester-nukleotider og fremgangsmåder til fremstilling af samme
DK3394272T3 (da) Sammensætninger og fremgangsmåder til effektiv målretning af transgener
DK3389636T3 (da) Sammensætninger og fremgangsmåder til fremstilling af proteinmikropartikler
DK3357343T3 (da) Fedtsammensætning og fremgangsmåde til fremstilling heraf
DK3302704T3 (da) Sammensætninger og fremgangsmåder til anvendelse af beta-hydroxy-beta-methylbutyrat (hmb) til reduktion af fedtmasse
DK3298466T3 (da) Fly og fremgangsmåde til stabilisering af et fly
DK3380525T3 (da) Farmaceutiske formuleringer og fremgangsmåder til anvendelse deraf
DK3288379T3 (da) Peptidsammensætninger og anvendelsesmåder
DK3072560T3 (da) Trampolinsystemer og fremgangsmåder til fremstilling og anvendelse deraf
DK3398598T3 (da) Sulfonamidderivat og fremstillingsmetode og anvendelse deraf
DK3373787T3 (da) Fremgangsmåde og indretning til tørring og plasmaunderstøttet desinficering af hænder
DK3250550T3 (da) Sammensætninger og fremgangsmåder til virussensibilisering